









Mercado
/
Acciones
/
nasdaq-neog
/

Neogen Corp

NEOG

4.650USD

-0.045-0.96%

Cierre 07/31, 16:00（ET）Cotizaciones retrasadas 15 min

1.01BCap. mercado

PérdidaP/E TTM



Neogen Corp

4.650

-0.045-0.96%

Descripción general Compañía Finanzas

Neogen Corporation and subsidiaries are engaged in developing, manufacturing and marketing a diverse line of products and services dedicated to food and animal safety. The Company has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. Its segments include Food Safety and Animal Safety. The Food Safety segment is primarily engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors. This segment also provides genomic identification and related interpretive bioinformatic services.

Información de la empresa

Símbolo de cotizaciónNEOG

Nombre de la empresaNeogen Corp

Fecha de salida a bolsaAug 23, 1989

Fundada en1981

Director ejecutivoMr. John Edward Adent

Número de empleados- -

Tipo de seguridadOrdinary Share

Fin del año fiscalAug 23

Dirección620 Lesher Pl

CiudadLANSING

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal48912

Teléfono15173729200

Sitio Webhttps://www.neogen.com/

Símbolo de cotizaciónNEOG

Fecha de salida a bolsaAug 23, 1989

Fundada en1981

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. John Edward Adent

President, Chief Executive Officer, Director

271.28K

+0.78%

Mr. David Hartman Naemura

Chief Financial Officer, Chief Operating Officer

124.19K

+73.77%

Mr. James C. (Jim) Borel

Independent Chairman of the Board

90.47K

+255.16%

Dr. Amy M. Rocklin, Ph.D.

Chief Legal & Compliance Officer

80.44K

+118.27%

Dr. William T. (Bill) Boehm, Ph.D.

Independent Director

35.59K

+16.34%

Ms. Aashima Gupta

Independent Director

27.99K

+133.42%

Dr. Catherine E. Woteki, Ph.D.

Independent Director

13.24K

+77.20%

Dr. Ronald D. Green, Ph.D.

Independent Director

12.78K

+46.92%

Ms. Andrea F. Wainer

Independent Director

6.09K

Mr. Thierry Bernard

Independent Director

5.62K

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. John Edward Adent

President, Chief Executive Officer, Director

271.28K

+0.78%

Mr. David Hartman Naemura

Chief Financial Officer, Chief Operating Officer

124.19K

+73.77%

Mr. James C. (Jim) Borel

Independent Chairman of the Board

90.47K

+255.16%

Dr. Amy M. Rocklin, Ph.D.

Chief Legal & Compliance Officer

80.44K

+118.27%

Dr. William T. (Bill) Boehm, Ph.D.

Independent Director

35.59K

+16.34%

Ms. Aashima Gupta

Independent Director

27.99K

+133.42%

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de jul

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Culture Media & Other

77.74M

35.18%

Bacterial & General Sanitation

39.88M

18.05%

Rodenticides, Insecticides & Disinfectants

35.64M

16.13%

Genomics Services

22.70M

10.27%

Natural Toxins, Allergens & Drug Residues

17.59M

7.96%

Other

27.41M

12.41%

Por regiónUSD

Nombre

Ganancia

Proporción

Domestic

115.36M

52.21%

International

105.61M

47.79%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Culture Media & Other

77.74M

35.18%

Bacterial & General Sanitation

39.88M

18.05%

Rodenticides, Insecticides & Disinfectants

35.64M

16.13%

Genomics Services

22.70M

10.27%

Natural Toxins, Allergens & Drug Residues

17.59M

7.96%

Other

27.41M

12.41%

Estadísticas de accionistas

Actualizado: hace 22 horas

Accionistas

Tipos de accionistas

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

13.19%

The Vanguard Group, Inc.

10.83%

William Blair Investment Management, LLC

4.33%

Baillie Gifford & Co.

4.22%

Gates Capital Management, Inc.

4.22%

Other

63.21%

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

13.19%

The Vanguard Group, Inc.

10.83%

William Blair Investment Management, LLC

4.33%

Baillie Gifford & Co.

4.22%

Gates Capital Management, Inc.

4.22%

Other

63.21%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

64.46%

Investment Advisor/Hedge Fund

43.57%

Hedge Fund

6.03%

Sovereign Wealth Fund

4.26%

Research Firm

3.39%

Pension Fund

1.74%

Bank and Trust

1.03%

Individual Investor

0.41%

Private Equity

0.31%

Participación institucional

Actualizado: mar., 1 de jul

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q2

712

280.17M

129.09%

-8.82M

2025Q1

753

280.62M

129.30%

-9.42M

2024Q4

764

265.86M

122.55%

-15.84M

2024Q3

778

258.29M

119.19%

-21.39M

2024Q2

791

255.45M

117.89%

-8.15M

2024Q1

783

241.86M

111.66%

-5.94M

2023Q4

783

234.38M

108.27%

-1.28M

2023Q3

770

225.33M

104.20%

-18.20M

2023Q2

761

232.20M

107.41%

-2.78M

2023Q1

759

225.00M

104.19%

-1.65M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

BlackRock Institutional Trust Company, N.A.

28.62M

13.19%

+5.44M

+23.46%

Mar 31, 2025

The Vanguard Group, Inc.

23.51M

10.83%

+1.91M

+8.86%

Mar 31, 2025

William Blair Investment Management, LLC

13.56M

6.25%

-787.83K

-5.49%

Mar 31, 2025

Baillie Gifford & Co.

9.16M

4.22%

-590.13K

-6.05%

Mar 31, 2025

Gates Capital Management, Inc.

9.16M

4.22%

+9.16M

Mar 31, 2025

Norges Bank Investment Management (NBIM)

14.81M

6.82%

-2.67M

-15.27%

Mar 31, 2025

State Street Global Advisors (US)

8.61M

3.97%

+282.73K

+3.40%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

8.46M

3.9%

+1.34M

+18.89%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

8.44M

3.89%

+1.50M

+21.56%

Mar 31, 2025

Mackenzie Investments

7.76M

3.57%

-67.86K

-0.87%

Mar 31, 2025

ETFs relacionados

Actualizado: dom., 6 de jul

Nombre

Proporción

SPDR S&P Health Care Equipment ETF

1.51%

Invesco S&P SmallCap Health Care ETF

0.83%

iShares Emergent Food and AgTech Multisector ETF

0.62%

Federated Hermes MDT Small Cap Core ETF

0.28%

VanEck Agribusiness ETF

0.26%

WisdomTree US SmallCap Quality Growth Fund

0.22%

Invesco S&P SmallCap 600 Pure Value ETF

0.22%

Amplify Etho Climate Leadership U.S. ETF

0.22%

First Trust Multi-Manager Small Cap Opportunities ETF

0.18%

ProShares MSCI Transformational Changes ETF

0.17%

SPDR S&P Health Care Equipment ETF

Proporción1.51%

Invesco S&P SmallCap Health Care ETF

Proporción0.83%

iShares Emergent Food and AgTech Multisector ETF

Proporción0.62%

Federated Hermes MDT Small Cap Core ETF

Proporción0.28%

VanEck Agribusiness ETF

Proporción0.26%

WisdomTree US SmallCap Quality Growth Fund

Proporción0.22%

Invesco S&P SmallCap 600 Pure Value ETF

Proporción0.22%

Amplify Etho Climate Leadership U.S. ETF

Proporción0.22%

First Trust Multi-Manager Small Cap Opportunities ETF

Proporción0.18%

ProShares MSCI Transformational Changes ETF

Proporción0.17%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones

Fecha

Tipo

Relación

May 12, 2021

Split

1>2

Fecha

Tipo

Relación

May 12, 2021

Split

1>2

KeyAI

